Activity Info

As endocrine disorders are on the rise, it’s very important that primary care providers take a role in patient management. Certain populations of diabetes patients particularly benefit from use of GLP 1 RAs. These benefits are so important that GLP 1 RAs have moved up in the treatment algorithms for diabetes. Reconsideration of the place of GLP 1 RAs in the treatment of diabetes is very recent, reflected in newest guidelines, and of significant educational importance for PCPs who may be unaware of this management approach for T2D. Adherence to therapy is a significant challenge clinicians face in the management of patients with T2D, necessitating an ongoing discussion of management strategies.